Skip to main content
. 2015 Nov 27;5:17220. doi: 10.1038/srep17220

Figure 4. Targeting of cells with biotin-NLP-RPE liposome.

Figure 4

(a) Gli36 human glioma cells expressing the EGFRvIII receptor and GFP were labeled with a biotinylated-antibody against EGFRvIII followed by streaptavidin-Alexa647 followed biotin-NLP-RPE, and analyzed by fluorescence microscopy for both Alexa647 and RPE. (b) Gli36 cells were infected with lentivirus vector expressing BAP-TM and GFP. These cells were labeled with Streptavidin-Alexa647 followed by biotin-NLP-RPE and analyzed as in (a).